Citigroup’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $50.4K | Buy |
|
|||||
|
2025
Q2 | $100 | Sell |
|
|||||
|
2025
Q1 | $151 | Sell |
|
|||||
|
2024
Q4 | $3.06K | Sell |
|
|||||
|
2024
Q3 | $206K | Buy |
|
|||||
|
2024
Q2 | $9.73K | Sell |
|
|||||
|
2024
Q1 | $13.8K | Sell |
|
|||||
|
2023
Q4 | $124K | Sell |
|
|||||
|
2023
Q3 | $1.15M | Buy |
|
|||||
|
2023
Q2 | $1.22M | Buy |
|
|||||
|
2023
Q1 | $1.11M | Buy |
|
|||||
|
2022
Q4 | $799K | Sell |
|
|||||
|
2022
Q3 | $1.23M | Buy |
|
|||||
|
2022
Q2 | $32K | Sell |
|
|||||
|
2022
Q1 | $373K | Sell |
|
|||||
|
2021
Q4 | $2.22M | Sell |
|
|||||
|
2021
Q3 | $2.25M | Buy |
|
|||||
|
2021
Q2 | $4.84M | Buy |
|
|||||
|
2021
Q1 | $4.13M | Buy |
|
|||||
|
2020
Q4 | $398K | Buy |
|
|||||
|
2020
Q3 | $287K | Sell |
|
|||||
|
2020
Q2 | $247K | Buy |
|
|||||
|
2020
Q1 | $56K | Buy |
|
|||||
|
2019
Q4 | $47K | Buy |
|
|||||
|
2019
Q3 | $19K | Sell |
|
|||||
|
2019
Q2 | $25K | Buy |
|
|||||
|
2019
Q1 | $49K | Buy |
|
|||||
|
2018
Q4 | $26K | Sell |
|
|||||
|
2018
Q3 | $43K | Buy |
|
|||||
|
2018
Q2 | $9K | Sell |
|
|||||
|
2018
Q1 | $8K | Sell |
|
|||||
|
2017
Q4 | $12K | Buy |
|
|||||
|
2017
Q3 | $18K | Sell |
|
|||||
|
2017
Q2 | $14K | Buy |
|
|||||
|
2017
Q1 | $11K | Sell |
|
|||||
|
2016
Q4 | $75K | Sell |
|
|||||
|
2016
Q3 | $162K | Buy |
|
|||||
|
2016
Q2 | $233K | Sell |
|
|||||
|
2016
Q1 | $331K | Buy |
|
|||||
|
2015
Q4 | $281K | Buy |
|
|||||
|
2015
Q3 | $110K | Buy |
|